Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Evaluate the Safety and Efficacy of Lerociclib in Participants With Advanced Breast Cancer

NCT05085002 is registered in ClinicalTrials.gov with EQRx, Inc. as lead sponsor.

NCT NCT05085002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05085002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Evaluate the Safety and Efficacy of Lerociclib in Participants With Advanced Breast Cancer
Lead sponsor
EQRx, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
December 21, 2021
Completion date
November 29, 2023
Enrollment
100 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer